from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Petition DENIED.
Reply of petitioners Amarin Pharma, Inc., et al. filed. (Distributed)
Brief of respondent Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited in opposition filed.
Motion to extend the time to file a response is granted in part and the time is extended to and including May 18, 2021.
Response to motion from petitioner Amarin Pharma, Inc., et al. filed.
Motion to extend the time to file a response from April 29, 2021 to June 14, 2021, submitted to The Clerk.
Response Requested. (Due April 29, 2021)
Brief amicus curiae of Aimed Alliance filed.
Brief amicus curiae of LiquidPower Specialty Products Inc. filed.
Waiver of right of respondents Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to respond filed.
Brief amicus curiae of US Inventor Inc. filed.
Waiver of right of respondent Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited to respond filed.
Petition for a writ of certiorari filed. (Response due March 18, 2021)
Amarin Pharma, Inc., et al., Petitioner, represented by Seth P. Waxman
Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., Respondent, represented by Constance S. Huttner
Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited, Respondent, represented by Charles Bennett Klein
Aimed Alliance, Amicus Curiae, represented by Ashley C. Parrish
LiquidPower Specialty Products Inc., Amicus Curiae, represented by Zachary D. Tripp
US Inventor Inc., Amicus Curiae, represented by Robert P. Greenspoon